Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

With federal covid sick leave gone, workers feel pressure to show up at work

Economists and public health experts alike say paid sick leave is an essential tool — like testing, masks and vaccines — in the effort to prevent covid-19 infection and keep workplaces safe.

30 Nov 2021

Predicting the far-field transmission of SARS-CoV-2 indoors

Researchers from the UK predicted the infection rate by the far-field airborne transmission of SARS-CoV-2 indoors.

30 Nov 2021

COVID-19 vaccination coverage and breakthrough infections in urban slums of India

A new study aimed to identify COVID-19 vaccination coverage, examine the factors responsible for COVID-19 vaccination coverage and vaccine hesitancy, study adverse events following immunization patterns after COVID-19 vaccination and determine the prevalence of breakthrough infection after COVID-19 vaccination.

30 Nov 2021

Improving access to health care is key to reducing HIV incidence

Many patients living with HIV in rural Africa are not receiving regular treatment, despite recent efforts to increase access to health care across the continent.

30 Nov 2021

Human LRRC15 protein is an inhibitory receptor for SARS-CoV-2 spike-mediated entry

In a recent study, published on the bioRxiv* preprint server, researchers identified human LRRC15 as an inhibitory receptor for SARS-CoV-2 entry, which directly binds to the receptor-binding domain (RBD) of the spike protein with a moderate affinity and inhibits spike-mediated entry.

29 Nov 2021

SARS-CoV-2 Delta spike increases viral virulence and inflammatory cytokine production

In a new study published on the bioRxiv* preprint server, scientists investigated several virological features of the Delta spike protein.

29 Nov 2021

Study on molnupiravir precursor NHC antiviral activity against SARS-CoV-2 variants of concern

In a new study, published on the bioRxiv* preprint server, scientists aimed to determine the reaction of the molnupiravir parent drug (NHC) to different SARS-CoV-2 Variants of Concern (VoCs). They also sought to establish the therapeutic window in a human lung cell model.

29 Nov 2021

Money recovered in corruption case used for providing life-saving support to vulnerable people in Chad

More than 150,000 people in Chad have been helped with lifesaving UK aid, including emergency food supplies, funded by £4.4 million recovered in a corruption case by the Serious Fraud Office.

29 Nov 2021

Saliva samples are effective and much friendlier way to measure SARS-CoV-2-specific antibodies

Saliva samples are easy to obtain and useful for measuring antibodies to SARS-CoV-2 in children, which could facilitate epidemiological surveillance in school settings.

29 Nov 2021

Childhood cancer diagnosis not delayed in Canada during the pandemic, study says

During the first 9 months of the COVID-19 pandemic, researchers did not find a significant difference in the number of new cancer diagnoses in Canadian children compared with before the pandemic, according to a study published in CMAJ.

29 Nov 2021

Novel influenza vaccine candidate shows promise

Researchers investigate the potential value of a new vaccine candidate for the influenza virus.

29 Nov 2021

New SARS-CoV-2 modeling suggests virus will remain a threat until the end of 2022

Researchers attempt to predict future transmission rates by identifying multiple scenarios that could occur over the next year.

29 Nov 2021

The Rockefeller Foundation and WHO review strategic directions of collaboration to promote global health

On 8-10 November 2021, Dr Naveen Rao, Senior Vice President, Health and other senior representatives from The Rockefeller Foundation joined World Health Organization representatives to review the strategic directions of collaboration between the two Organizations.

29 Nov 2021

European study endorses dashboards for public reporting during the COVID-19 pandemic

Researchers explore the development of COVID-19 dashboards during the first year of the pandemic.

29 Nov 2021

Study: About 1 in 100 COVID-19 patients likely develop central nervous system complications

The largest multi-institutional international study to date on brain complications of COVID-19 has found that approximately one in 100 patients hospitalized with COVID-19 will likely develop complications of the central nervous system.

29 Nov 2021

Extended host range for SARS-CoV-2 variants of concern

Researchers used viral pseudotyping to examine whether variants of concern had different host ACE2 receptor usage patterns.

29 Nov 2021

COVID-19 surges in the USA, Mexico, and Canada

The authors analyzed the waxing and waning patterns of reported SARS-CoV-2 cases in all states and provinces in the USA, Mexico, and Canada, and across all counties in the USA.

29 Nov 2021

Study: Small percentage of college athletes with COVID-19 develop myocarditis

A small but significant percentage of college athletes with COVID-19 develop myocarditis, a potentially dangerous inflammation of the heart muscle, that can only be seen on cardiac MRI, according to a study being presented today at the annual meeting of the Radiological Society of North America.

29 Nov 2021

Do we need COVID-19 vaccine boosters?

An article published recently in the Journal of Virology explored the science behind COVID-19 vaccine boosters.

29 Nov 2021

Interventions most effective in containing SARS-CoV-2 spread

A new study finds that viral transmission cannot be contained effectively using individual interventions at realistic levels of compliance.

29 Nov 2021

Pandemic News and Research

Further Reading

With federal covid sick leave gone, workers feel pressure to show up at work

Predicting the far-field transmission of SARS-CoV-2 indoors

COVID-19 vaccination coverage and breakthrough infections in urban slums of India

Improving access to health care is key to reducing HIV incidence

Human LRRC15 protein is an inhibitory receptor for SARS-CoV-2 spike-mediated entry

SARS-CoV-2 Delta spike increases viral virulence and inflammatory cytokine production

Study on molnupiravir precursor NHC antiviral activity against SARS-CoV-2 variants of concern

Money recovered in corruption case used for providing life-saving support to vulnerable people in Chad

Saliva samples are effective and much friendlier way to measure SARS-CoV-2-specific antibodies

Childhood cancer diagnosis not delayed in Canada during the pandemic, study says

Novel influenza vaccine candidate shows promise

New SARS-CoV-2 modeling suggests virus will remain a threat until the end of 2022

The Rockefeller Foundation and WHO review strategic directions of collaboration to promote global health

European study endorses dashboards for public reporting during the COVID-19 pandemic

Study: About 1 in 100 COVID-19 patients likely develop central nervous system complications

Extended host range for SARS-CoV-2 variants of concern

COVID-19 surges in the USA, Mexico, and Canada

Study: Small percentage of college athletes with COVID-19 develop myocarditis

Do we need COVID-19 vaccine boosters?

Interventions most effective in containing SARS-CoV-2 spread

Best practices - optimize qPCR processes for pathogen detection eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News